Chevy Chase Trust Holdings Inc. lowered its position in Becton Dickinson and Co. (NYSE:BDX) by 3.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 253,583 shares of the company’s stock after selling 9,571 shares during the period. Chevy Chase Trust Holdings Inc. owned about 0.12% of Becton Dickinson and worth $45,577,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in BDX. Point72 Asia Hong Kong Ltd purchased a new position in shares of Becton Dickinson and during the second quarter valued at about $119,000. Acrospire Investment Management LLC raised its position in shares of Becton Dickinson and by 458.0% in the second quarter. Acrospire Investment Management LLC now owns 731 shares of the company’s stock valued at $124,000 after buying an additional 600 shares during the period. Iowa State Bank purchased a new position in shares of Becton Dickinson and during the second quarter valued at about $137,000. First Personal Financial Services raised its position in shares of Becton Dickinson and by 101.7% in the second quarter. First Personal Financial Services now owns 827 shares of the company’s stock valued at $140,000 after buying an additional 417 shares during the period. Finally, Global X Management Co. LLC raised its position in shares of Becton Dickinson and by 228.5% in the second quarter. Global X Management Co. LLC now owns 946 shares of the company’s stock valued at $160,000 after buying an additional 658 shares during the period. 82.26% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Shares of Becton Dickinson and Co. (NYSE:BDX) traded down 0.90% during midday trading on Friday, hitting $171.86. 1,182,371 shares of the stock were exchanged. Becton Dickinson and Co. has a 1-year low of $129.50 and a 1-year high of $181.76. The firm’s 50 day moving average is $173.95 and its 200-day moving average is $171.84. The stock has a market capitalization of $36.59 billion, a price-to-earnings ratio of 38.28 and a beta of 1.04.

Becton Dickinson and (NYSE:BDX) last posted its quarterly earnings data on Thursday, November 3rd. The company reported $2.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.09 by $0.03. Becton Dickinson and had a net margin of 7.82% and a return on equity of 24.44%. The company earned $3.23 billion during the quarter, compared to analysts’ expectations of $3.22 billion. During the same period in the prior year, the company posted $1.94 earnings per share. Becton Dickinson and’s revenue for the quarter was up 5.6% compared to the same quarter last year. On average, analysts predict that Becton Dickinson and Co. will post $9.52 EPS for the current year.

Several equities analysts have recently issued reports on BDX shares. Leerink Swann reissued a “hold” rating on shares of Becton Dickinson and in a report on Tuesday, August 9th. Zacks Investment Research lowered shares of Becton Dickinson and from a “buy” rating to a “hold” rating in a report on Wednesday. Cowen and Company reissued an “outperform” rating and issued a $185.00 price target on shares of Becton Dickinson and in a report on Tuesday, August 16th. Citigroup Inc. lowered shares of Becton Dickinson and from a “neutral” rating to a “sell” rating and decreased their price target for the company from $167.00 to $165.00 in a report on Friday, September 23rd. Finally, Jefferies Group boosted their price target on shares of Becton Dickinson and from $190.00 to $192.00 and gave the company a “buy” rating in a report on Thursday, July 28th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $175.39.

In other Becton Dickinson and news, insider Stephen Sichak sold 10,352 shares of the firm’s stock in a transaction on Friday, November 4th. The shares were sold at an average price of $176.10, for a total value of $1,822,987.20. Following the completion of the sale, the insider now directly owns 26,892 shares in the company, valued at $4,735,681.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Linda M. Tharby sold 11,704 shares of the firm’s stock in a transaction on Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total transaction of $2,074,768.08. Following the completion of the sale, the insider now owns 22,146 shares of the company’s stock, valued at $3,925,821.42. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Receive News & Stock Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related stocks with our FREE daily email newsletter.